Shire says it is now in detailed talks with fellow pharmaceutical company AbbVie over its new takeover proposal, valued at more than $53 billion
read more
Shire says it is now in detailed talks with fellow pharmaceutical company AbbVie over its new takeover proposal, valued at more than $53 billion
read more